Kidswell Bio Corporation 4584.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 11:24 AM JST
274.00quote price arrow up+14.00 (+5.38%)
Volume
750,200
52 week range
254.00 - 864.00
Loading...
  • Open261.00
  • Day High298.00
  • Day Low261.00
  • Prev Close260.00
  • 52 Week High864.00
  • 52 Week High Date09/13/21
  • 52 Week Low254.00
  • 52 Week Low Date05/17/22

Key Stats

  • Market Cap87M
  • Shares Out31.44M
  • 10 Day Average Volume405,225
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.42

KEY STATS

  • Open261.00
  • Day High298.00
  • Day Low261.00
  • Prev Close260.00
  • 52 Week High864.00
  • 52 Week High Date09/13/21
  • 52 Week Low254.00
  • 52 Week Low Date05/17/22
  • Market Cap87M
  • Shares Out31.44M
  • 10 Day Average Volume405,225
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-44.42

RATIOS/PROFITABILITY

  • EPS (TTM)-31.80
  • P/E (TTM)-8.62
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kidswell Bio Corporation

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kidswell Bio Corp, formerly Gene Techno Science Co Ltd, is a Japan-based company mainly engaged in the development of biopharmaceuticals. The biosimilar business is engaged in the research, development and provision of filgrastim biosimilar products and pegfilgrastim biosimilar products for cancer, darbepoetin alfa biosimilar products for renal diseases, and ranibizumab biosimilar products for eye diseases. The new biopharmaceutical business is engaged in the research and...
Masaharu Tani
President, Chief Executive Officer, Representative Director
Yasuo Sakae
Chief Financial Officer, Executive Officer, Chief Director of Business Administration
Address
3F, Kanayama Bldg., 1-2-12, Shinkawa
Chuo-ku, TKY
104-0033
Japan